Dominique Valla

47.8k total citations · 4 hit papers
487 papers, 28.7k citations indexed

About

Dominique Valla is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Dominique Valla has authored 487 papers receiving a total of 28.7k indexed citations (citations by other indexed papers that have themselves been cited), including 347 papers in Hepatology, 259 papers in Epidemiology and 167 papers in Surgery. Recurrent topics in Dominique Valla's work include Liver Disease and Transplantation (266 papers), Liver Disease Diagnosis and Treatment (233 papers) and Organ Transplantation Techniques and Outcomes (81 papers). Dominique Valla is often cited by papers focused on Liver Disease and Transplantation (266 papers), Liver Disease Diagnosis and Treatment (233 papers) and Organ Transplantation Techniques and Outcomes (81 papers). Dominique Valla collaborates with scholars based in France, Spain and Italy. Dominique Valla's co-authors include François Durand, Richard Moreau, Pierre‐Emmanuel Rautou, Didier Lebrec, Bertrand Condat, Patrick Marcellin, Aurélie Plessier, Claude Degott, Valérie Vilgrain and Jacques Belghiti and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Dominique Valla

469 papers receiving 27.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The burden of liver disease in Europe: A review of available epidemiological data

2013 984 citations Dominique Valla et al. Journal of Hepatology profile →
Liver sinusoidal endothelial cells: Physiology and role in liver diseases

2016 743 citations François Durand, Richard Moreau et al. Journal of Hepatology profile →
Vascular disorders of the liver # †

2008 616 citations Dominique Valla et al. Hepatology profile →
Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases

2020 325 citations Juan Carlos García‐Pagán, Dominique Valla et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dominique Valla France	96	21.0k	16.8k	9.7k	2.1k	1.9k	487	28.7k
Andrew K. Burroughs United Kingdom	93	29.5k 1.4×	24.1k 1.4×	13.2k 1.4×	2.2k 1.0×	389 0.2×	506	38.8k
Harry L.A. Janssen Netherlands	82	20.9k 1.0×	21.4k 1.3×	2.7k 0.3×	2.9k 1.4×	937 0.5×	430	29.0k
K. Rajender Reddy United States	88	28.3k 1.3×	24.9k 1.5×	5.3k 0.5×	2.4k 1.1×	790 0.4×	586	37.2k
Patrick S. Kamath United States	85	23.6k 1.1×	22.4k 1.3×	13.3k 1.4×	2.3k 1.1×	449 0.2×	423	34.2k
Thomas E. Starzl United States	117	22.4k 1.1×	12.7k 0.8×	32.3k 3.3×	4.6k 2.2×	930 0.5×	1.3k	56.9k
P. Cacoub France	91	10.4k 0.5×	10.1k 0.6×	3.8k 0.4×	1.9k 0.9×	3.0k 1.6×	754	32.3k
Guadalupe García–Tsao United States	78	23.9k 1.1×	20.8k 1.2×	11.3k 1.2×	839 0.4×	593 0.3×	252	28.1k
Ronald W. Busuttil United States	99	18.3k 0.9×	10.9k 0.6×	19.8k 2.0×	6.1k 2.9×	481 0.2×	757	37.7k
John J. Fung United States	104	14.7k 0.7×	10.6k 0.6×	21.1k 2.2×	4.3k 2.0×	585 0.3×	1.2k	44.3k
Jacques Belghiti France	99	18.2k 0.9×	10.9k 0.6×	17.0k 1.7×	2.8k 1.4×	382 0.2×	522	32.2k

Countries citing papers authored by Dominique Valla

Since Specialization

Citations

This map shows the geographic impact of Dominique Valla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominique Valla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominique Valla more than expected).

Fields of papers citing papers by Dominique Valla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominique Valla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominique Valla. The network helps show where Dominique Valla may publish in the future.

Co-authorship network of co-authors of Dominique Valla

This figure shows the co-authorship network connecting the top 25 collaborators of Dominique Valla. A scholar is included among the top collaborators of Dominique Valla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominique Valla. Dominique Valla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poynard, Thierry, Olivier Deckmyn, Valentina Peta, et al.. (2023). Prospective direct comparison of non‐invasive liver tests in outpatients with type 2 diabetes using intention‐to‐diagnose analysis. Alimentary Pharmacology & Therapeutics. 58(9). 888–902. 5 indexed citations

Cassinat, Bruno, Barbara Mora, Emmanuelle Verger, et al.. (2020). Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses. Blood Advances. 4(15). 3708–3715. 30 indexed citations

Guérin, Florent, Valérie A. McLin, O. Ackermann, et al.. (2020). Congenital portosystemic shunts. Clinics and Research in Hepatology and Gastroenterology. 44(4). 452–459. 10 indexed citations

Kutala, B., Jérémie Guedj, Tarik Asselah, et al.. (2014). Impact of Treatment against Hepatitis C Virus on Overall Survival of Naive Patients with Advanced Liver Disease. Antimicrobial Agents and Chemotherapy. 59(2). 803–810. 9 indexed citations

Estrabaud, Emilie, Martine Lapalus, Philippe Broët, et al.. (2014). Reduction of MicroRNA 122 Expression in IFNL3 CT/TT Carriers and during Progression of Fibrosis in Patients with Chronic Hepatitis C. Journal of Virology. 88(11). 6394–6402. 29 indexed citations

Hopt, Ulrich T., et al.. (2014). Management of Portal/Mesenteric Vein Occlusion. PubMed. 30(6). 2–2. 3 indexed citations

Smalberg, Jasper H., Lidia R. Arends, Dominique Valla, et al.. (2012). Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood. 120(25). 4921–4928. 243 indexed citations

Sersté, Thomas, Christian Mélot, Claire Francoz, et al.. (2010). Deleterious Effects of Beta-Blockers on Survival in Patients With Cirrhosis and Refractory Ascites†,‡. Hepatology. 52(3). 1017–1022. 348 indexed citations

Valla, Dominique. (2009). DIAGNOSIS AND THERAPEUTIC MANAGEMENT OF HEPATOPORTAL SCLEROSIS. 79(1). 1 indexed citations

10.

Kiladjian, Jean‐Jacques, Francisco Cervantes, Frank W.G. Leebeek, et al.. (2008). The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood. 111(10). 4922–4929. 227 indexed citations

11.

Asselah, Tarik, Ivan Bièche, Audrey Sabbagh, et al.. (2008). Gene expression and hepatitis C virus infection. Gut. 58(6). 846–858. 74 indexed citations

12.

Moucari, Rami, Pierre‐Emmanuel Rautou, Dominique Cazals‐Hatem, et al.. (2008). Hepatocellular carcinoma in Budd–Chiari syndrome: characteristics and risk factors. Gut. 57(6). 828–835. 105 indexed citations

13.

Murad, Sarwa Darwish, W. Ray Kim, Piet C. de Groen, et al.. (2007). Can the Model for End-Stage Liver Disease Be Used to Predict the Prognosis in Patients with Budd-Chiari Syndrome?. Liver Transplantation. 13(6). 867–874. 23 indexed citations

14.

Murad, Sarwa Darwish, Aurélie Plessier, Massimo Primignani, et al.. (2007). [3] A PROSPECTIVE FOLLOW-UP STUDY ON 163 PATIENTS WITH BUDD-CHIARI SYNDROME: RESULTS FROM THE EUROPEAN NETWORK FOR VASCULAR DISORDERS OF THE LIVER (EN-VIE). Journal of Hepatology. 46. S4–S4. 17 indexed citations

15.

Francque, Sven, Bertrand Condat, Tarik Asselah, et al.. (2004). Multifactorial aetiology of hepatic infarction. European Journal of Gastroenterology & Hepatology. 16(4). 411–415. 13 indexed citations

16.

Rotily, Michel, Sandrine Loubière, Isabelle Portal, et al.. (2002). Facteurs associés à la proposition du dépistage de l'hépatite C en médecine générale.. Gastroentérologie Clinique et Biologique. 26(3). 3 indexed citations

17.

Durand, François, Jacques Bernuau, G Mentha, et al.. (2001). Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine. Gut. 48(6). 849–852. 77 indexed citations

18.

Pateron, Dominique, Pascale Beyne, Thierry Laperche, et al.. (1999). Elevated Circulating Cardiac Troponin I in Patients With Cirrhosis. Hepatology. 29(3). 640–643. 100 indexed citations

19.

Grangé, Jean‐Didier, Armand Abergel, Xavier Amiot, et al.. (1995). [Interactions between chronic viral hepatitis C and pregnancy].. PubMed. 19(5). 520–4. 10 indexed citations

20.

Roulot, Dominique, Dominique Valla, Françoise Brun‐Vézinet, et al.. (1987). Cholangitis in the acquired immunodeficiency syndrome: report of two cases and review of the literature.. Gut. 28(12). 1653–1660. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact